A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections.
Also Known As:
Factor P, Complement; Complement Factor P
Networked: 369 relevant articles (6 outcomes, 26 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results


1. Song, Wen-Chao: 8 articles (10/2014 - 01/2008)
2. Stover, Cordula: 6 articles (08/2014 - 04/2010)
3. Stover, Cordula M: 5 articles (04/2015 - 03/2008)
4. Schwaeble, Wilhelm J: 5 articles (04/2015 - 03/2008)
5. Miwa, Takashi: 5 articles (10/2014 - 01/2008)
6. Meri, Seppo: 4 articles (01/2012 - 05/2005)
7. Byrne, Simon: 3 articles (01/2015 - 01/2014)
8. Sato, Sayaka: 3 articles (10/2014 - 01/2013)
9. Lesher, Allison M: 3 articles (10/2014 - 01/2013)
10. Gullipalli, Damodar: 3 articles (10/2014 - 01/2013)

Related Diseases

1. Infection
2. Arthritis (Polyarthritis)
3. Reperfusion Injury
4. Convalescence
5. Kidney Diseases (Kidney Disease)

Related Drugs and Biologics

1. Complement System Proteins (Complement)
2. Antigen-Antibody Complex (Immune Complex)
3. Lipopolysaccharides
4. Anaphylatoxins
5. CD55 Antigens (Decay Accelerating Factor)
6. Collagen
7. Complement Factor B (Factor B)
8. Immunoglobulin A (IgA)
9. Immunoglobulin G (IgG)
10. Antibodies

Related Therapies and Procedures

1. Homologous Transplantation (Allograft)
2. Radiotherapy
3. Aftercare (After-Treatment)
4. Transplants (Transplant)
5. Ligation

blog comments powered by Disqus
for Infection,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 19746 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>